View on PubMed [PubMed] Pentadecapeptide BPC 157 Counteracts L-NAME-Induced Catalepsy in Rat Models (2021) Controlled rat study in which BPC-157 counteracted dopaminergic and NMDA-receptor-related motor disturbances and haloperidol-induced catalepsy while modulating the nitric oxide system
This product is not a drug, food, cosmetic, or dietary supplement, has not been evaluated or approved by the FDA, and is not intended to diagnose, treat, cure or prevent any disease
[So many people are] scared of vaccines and pharmaceuticals, but then were like, Oh, I want this peptide, even though it says Not for human use on the bottle. Are there new business opportunities for BPC-157
The principle of stress-response hormesis is increasingly finding application in studies of aging, where hormetic increases in life span have been seen in several animal models
N-hexanoic-Try-Ile-(6)-amino hexanoic amide